Erasca, INC Form 4 insider transactions

Charles S. Fuchs, President, R&D of Erasca, Inc., received 1,300,000 shares of common stock on August 10, 2026.

Valerie Denise Harding, a Director at Erasca, Inc., acquired stock options for 29,888 shares of common stock on June 26, 2026.

Erasca, Inc. director Jean I. Liu acquired 29,888 stock options with an exercise price of $16.01, vesting on June 26, 2027.

Erasca, Inc. director Pratik S. Multani acquired 29,888 stock options with an exercise price of $16.01, vesting on June 26, 2027.

Director Alexander W. Casdin of Erasca, Inc. acquired 29,888 stock options on June 26, 2026, as detailed in a Form 4 filing.

Director Julie Hambleton acquired 29,888 stock options in Erasca, Inc. on June 26, 2026, with an exercise price of $16.01.

Director James Arthur Bristol acquired 29,888 stock options in Erasca Inc. (ERAS) on June 26, 2026, with vesting contingent on continued service.

Ebun Garner, Chief Legal Officer of Erasca, Inc., reported transactions involving the acquisition and disposition of common stock, executed under a Rule 10b5-1 trading plan.

Erasca's Chief Medical Officer, Shannon Morris, exercised stock options and immediately sold 20,000 shares of common stock for a significant gain, pursuant to a pre-arranged 10b5-1 trading plan.

Erasca, Inc. Chairman and CEO Jonathan E. Lim acquired 2,000,000 stock options with an exercise price of $10.31, vesting monthly over four years.

Erasca's CFO and CBO, David M. Chacko, acquired additional common stock and received a significant stock option grant, increasing his beneficial ownership.

Erasca, Inc.'s Chief Medical Officer, Shannon Morris, was granted 625,000 stock options with an exercise price of $10.31, vesting over four years.

Erasca, Inc. Director Michael David Varney was granted 96,000 stock options with an exercise price of $10.31, vesting monthly over four years.

Erasca, Inc.'s General Counsel and Corporate Secretary, Ebun Garner, was granted 560,000 stock options with an exercise price of $10.31, vesting over four years.

Erasca's General Counsel, Ebun Garner, exercised stock options and subsequently sold 120,000 shares of common stock, while also acquiring additional shares through an employee plan.

Erasca, Inc. Director James Arthur Bristol received 37,762 stock options with a $3.72 exercise price in lieu of 2026 cash compensation.

Erasca, Inc. Director Jean I. Liu received 20,617 stock options with an exercise price of $3.72 in lieu of 2026 cash compensation.

Erasca, Inc. director Pratik S. Multani received 19,532 stock options with a $3.72 exercise price in lieu of 2026 cash compensation for board service.

Erasca, Inc. Director Valerie Denise Harding received 24,306 stock options in lieu of 2026 cash compensation, aligning her interests with shareholders.

Erasca Director Alexander W. Casdin received 23,872 stock options with a $3.72 exercise price in lieu of 2026 cash compensation.

Erasca, Inc. Director Michael David Varney was granted 120,000 stock options with an exercise price of $1.45, vesting fully on June 24, 2026.

Erasca, Inc. Director Jean I Liu was granted 120,000 stock options with an exercise price of $1.45, vesting fully on June 24, 2026.

Erasca, Inc. Director Julie Hambleton was granted 120,000 stock options with an exercise price of $1.45, vesting on June 24, 2026.

Valerie Denise Harding, a Director at Erasca, Inc., has acquired 120,000 stock options with an exercise price of $1.45, vesting fully on June 24, 2026.

Erasca, Inc. Director Pratik S Multani has acquired 120,000 stock options with an exercise price of $1.45, vesting fully on June 24, 2026.

Erasca, Inc. Director James Arthur Bristol was granted 120,000 stock options with an exercise price of $1.45, vesting fully on June 24, 2026.

Alexander W. Casdin, a Director and 10% Owner of Erasca, Inc., was granted 120,000 stock options with an exercise price of $1.45, vesting in June 2026.

Pratik S Multani, a Director at Erasca, Inc., has reclassified 6,200 shares of common stock from direct to indirect ownership via a family trust for estate planning purposes, with no change to his total beneficial ownership.

Ebun Garner, General Counsel & Corporate Secretary of Erasca, Inc., reports the acquisition of stock options for 50,000 shares of common stock.

David M. Chacko, CFO and CBO of Erasca, Inc., reports the acquisition of common stock and stock options.